See also this year's filing and all EDGAR filings for this company.
PDF Report 0000912183_2014_Cubist_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000912183, Cubist Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 869,769,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,104,084,000 |
| 2 | PropertyPlantAndEquipmentNet | 177,544,000 |
| 3 | remainder_Assets | 994,424,000 |
| 4 | LiabilitiesCurrent | 310,828,000 |
| 5 | LiabilitiesNoncurrent | 31,726,000 |
| 6 | remainder_Liabilities | 1,409,536,000 |
| 7 | CostOfGoodsAndServicesSold | 275,501,809 |
| 8 | SellingGeneralAndAdministrativeExpense | 351,882,728 |
| 9 | ResearchAndDevelopmentExpense | 918,358,639 |
| 10 | remainder_Expenses | -3,143,765 |
| 11 | remainder_Revenues | 1,099,647,628 |
| 12 | remainder_NetIncome | -69,545,178 |
| 13 | remainder_ComprehensiveNetIncome | 1,012,168 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,145,821,000 |
| 1 | Liabilities | 1,752,090,000 |
| 2 | Expenses | 1,542,599,411 |
| 3 | Revenues | 1,099,647,628 |
| 4 | StockholdersEquity | 1,393,731,000 |
| 5 | NetIncome | -512,496,961 |
| 6 | ComprehensiveNetIncome | -511,990,877 |
| 7 | BaseVar | 3,805,357,692 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.03 |
| 9 | EconomicCapitalRatio | 2.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
